Modified Dental Anxiety Scale (MDAS)
Modified Dental Anxiety Scale · Also known as: MDAS, Modified Dental Anxiety Scale (MDAS)
The Modified Dental Anxiety Scale (MDAS) is a brief 5-item self-report instrument measuring anxiety anticipation and response to common dental situations. Developed by Humphris and colleagues in 1995 as a refinement of prior instruments, the MDAS has become the gold standard for rapid dental anxiety screening in clinical practice and research. Its brevity, psychometric rigor, and clinical utility have made it the most frequently used measure of dental anxiety internationally.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The MDAS is used in primary dental practice for rapid identification of anxious patients at initial consultation, enabling tailored treatment planning and behavior management allocation. It is the standard outcome measure in randomized trials evaluating cognitive-behavioral therapy, exposure therapy, or pharmacological interventions (nitrous oxide, sedatives) for dental anxiety. The MDAS is also used in epidemiological surveys to estimate prevalence of dental anxiety and identify vulnerable populations, and in health services research to assess whether anxiety management reduces avoidance and improves oral health outcomes.
Strengths & limitations
- Extremely brief (5 items, 2-3 minute administration) and highly feasible for routine clinical screening without overburdening patients or staff
- Psychometrically robust with high internal consistency (Cronbach α = 0.86-0.90) and excellent test-retest reliability (ICC = 0.81-0.92) across diverse samples
- Validated internationally with translations in 20+ languages and confirmed measurement equivalence across cultures, making it ideal for multicenter and cross-national research
- Sensitive and responsive to intervention; demonstrated reduction following cognitive-behavioral therapy, exposure-based treatment, and sedation, with effect sizes typically moderate to large
- Predictive validity: MDAS identifies patients at risk for appointment avoidance, non-completion, and poorer oral health outcomes
- Brief scale (5 items) provides limited item diversity; cannot separately assess distinct anxiety dimensions (anticipatory vs. in-vivo, fear vs. avoidance) with precision
- Ordinal scale; parametric assumptions may be violated; non-parametric tests and ordinal regression preferable
- Self-report only; does not capture physiological anxiety markers (heart rate, cortisol) or observed avoidance behavior, which may differ from subjective ratings
- Does not distinguish dental anxiety from dental phobia or identify comorbid anxiety disorders; clinical assessment and structured psychiatric interview needed for differential diagnosis
Frequently asked
Is the MDAS suitable for children under 13?
The MDAS was validated in adolescents 13+ and adults. For younger children (5-12), the DFA or other child-specific instruments are more developmentally appropriate. However, some clinicians use MDAS in older school-age children (11-13) with parental guidance.
What is the minimal clinically important difference (MCID) for MDAS?
Published MCID estimates range from 4 to 6 points. A reduction of ≥5 points on MDAS represents clinically meaningful improvement in anxiety; within-patient change of 1-2 points may reflect measurement variability.
How does MDAS correlate with observed anxiety behavior during treatment?
Correlation between MDAS and observed behavioral anxiety during treatment is moderate to strong (r = 0.60-0.75), indicating good but imperfect correspondence. Some patients score high but manage with coping; others score lower but exhibit avoidance. Clinical observation complements MDAS.
Can the MDAS be administered repeatedly to track anxiety over time?
Yes, the MDAS is stable with good test-retest reliability (≥0.81) and responsive to intervention. Repeated administration at each visit is feasible and documents anxiety trajectory. Monthly or quarterly monitoring is standard in anxiety intervention trials.
Sources
- Humphris, G. M., Morrison, T., & Lindsay, S. J. (1995). The Modified Dental Anxiety Scale: validation and United Kingdom norms. Community Dentistry and Oral Epidemiology, 23(6), 326-330. link ↗
How to cite this page
ScholarGate. (2026, June 3). Modified Dental Anxiety Scale. ScholarGate. https://scholargate.app/en/dentistry/dental-anxiety-modified-scale
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
Compare side by side →